MR Imaging Characteristics of Protoplasmic Astrocytomas
Overview
Affiliations
Introduction: Protoplasmic astrocytomas are a poorly recognized and uncommon subtype of astrocytoma. While usually categorized with other low-grade gliomas, there is literature to suggest that protoplasmic astrocytomas have differences in biology compared to other gliomas in this group. This paper presents the MR imaging characteristics of a series of eight protoplasmic astrocytomas.
Methods: We retrospectively reviewed MR images and histopathology of eight consecutive cases of histologically proven protoplasmic astrocytomas.
Results: Patients ranged from 17 to 51 years of age with a 5:3 male to female ratio. The tumors were located in the frontal or temporal lobes and tended to be large, well defined, and had a very high signal on T2 (close to cerebrospinal fluid). Generally, a large proportion of the tumor showed substantial signal suppression on T2 fluid-attenuated inversion recovery (FLAIR). Six of the eight lesions also demonstrated a partial or complete rim of reduced apparent diffusion coefficient (ADC) around the T2 FLAIR suppressing portion.
Conclusions: The possibility that a primary cerebral neoplasm represents a protoplasmic astrocytoma should be considered in a patient with a large frontal or temporal tumor that has a very high signal on T2 with a large proportion of the tumor showing substantial T2 FLAIR suppression. A further clue is a partial or complete rim of reduced ADC.
Hwa J, Wong A, Jung S, Wu C Childs Nerv Syst. 2024; 40(8):2271-2278.
PMID: 38884778 DOI: 10.1007/s00381-024-06487-5.
Malik P, Soliman R, Chen Y, Munoz D, Das S, Bharatha A Neuroradiology. 2024; 66(4):521-530.
PMID: 38347151 DOI: 10.1007/s00234-024-03297-z.
Dagher S, Lochner R, Ozkara B, Schomer D, Wintermark M, Fuller G Neuroradiol J. 2023; 37(4):441-453.
PMID: 37924213 PMC: 11366202. DOI: 10.1177/19714009231212375.
T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma.
Wagner M, Nobre L, Namdar K, Khalvati F, Tabori U, Hawkins C AJNR Am J Neuroradiol. 2023; 44(7):841-845.
PMID: 37348970 PMC: 10337621. DOI: 10.3174/ajnr.A7916.
Xu J, Meng Y, Qiu K, Topatana W, Li S, Wei C Front Oncol. 2022; 12:892056.
PMID: 35965542 PMC: 9363668. DOI: 10.3389/fonc.2022.892056.